NEW YORK (Reuters Health) - For the first time, researchers have
evidence of an association between renal cell carcinoma and multiple
myeloma, a type of blood cancer, one that "cannot be explained by
random incidence alone," they say.
"I think general oncologists as well as myeloma and renal cancer
physicians should be aware of this association," Dr. Mohamad A. Hussein
of the H. Lee Moffitt Cancer and Research Institute in Tampa, Florida,
noted in comments to Reuters Health.
Renal cell carcinoma begins in the kidney cells and although it may
progress slowly, it is very resistance to chemotherapy. Multiple
myeloma, which may also progress slowly, is likewise resistant to
treatment. It begins in the blood's plasma cells, a type of white blood
cell that is part of the immune system. Over time, myeloma cells build
up in bone marrow and then in the solid parts of bone.
In a review of data from patients referred to the Cleveland Clinic
between 1990 and 2005, Hussein and colleagues identified 1,100 patients
with multiple myeloma, 2,704 with renal cell carcinoma, and 8 with both
types of cancer.
In 4 of the 8 patients, renal cell carcinoma was diagnosed 3 to 46
months after the multiple myeloma diagnosis. In the remaining 4, renal
cell carcinoma was diagnosed 1 to 108 months before the multiple
myeloma. Seven of the 8 patients were first diagnosed with renal cell
carcinoma on the right side.
"The probability of this association was much higher than that
expected in the general population," the researchers note in the
medical journal BJU International. "No clear treatment-related,
environmental, genetic or immune-mediated common factors can fully
explain this association."
The investigators point out that interleukin-6 supports the growth
and expansion of both types of cancer. Interleukin-6 is a "cytokine"
that normally enhances the body's immune response to disease and
infection.
"I think the take-home message," Hussein said, "is that after active
therapy for myeloma, if the kidney lesion does not clear -- especially
if it is affecting the right kidney -- renal cell cancer should be
considered."
-----
Craig